---
document_datetime: 2025-09-29 12:23:28
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/zefylti-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: zefylti-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.5495777
conversion_datetime: 2025-12-22 16:51:36.272229
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Zefylti

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                            |
|----------------------|-------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|----------------------------------------------------|
| Variation type IB /  | C.I.2 Change(s) in the Summary of Product | 26/09/2025                          |                                             | SmPC, Annex                      | To update Section 4.8 of the SmPC and Section 4 of |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000296307                     | Characteristics, Labelling or Package Leaflet of a generic/hybrid/biosimilar medicinal products following assessment of the same change for the reference product - C.I.2.a Implementation of change(s) for which no new additional data is required to be submitted by the MAH - Accepted C.I.2.a (Type IB) - To update Section 4.8 of the SmPC and Section 4 of the PL to add the adverse reaction 'Extramedullary haematopoiesis' with frequency 'Rare', following approval of the same change to the reference product, Neupogen. In addition, the MAH took the opportunity to implement editorial changes to align the address of the manufacturer of the biological active substance, listed in Annex II, with SPOR OMS, align the address of the MAH in Section 7 of the SmPC with the address in SPOR OMS, Labelling and PL, and implemented typographic and formatting corrections in line with the QRD template   |            |     | II, Labelling and PL   | the PL to add the adverse reaction 'Extramedullary haematopoiesis' with frequency 'Rare', following approval of the same change to the reference product, Neupogen.   |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Variation type IB / EMA/VR/0000291959 | B.II.b.4 Change in the batch size (including batch size ranges) of the finished product - B.II.b.4.a Up to 10-fold compared to the originally approved batch size - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 02/09/2025 | N/A |                        |                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

| Article 61(3) / EMA/N/0000264207   | - Notification acc. Article 61(3) - Accepted Update of the package leaflet to introduce a list of local representatives.   | 14/04/2025   | PL   |
|------------------------------------|----------------------------------------------------------------------------------------------------------------------------|--------------|------|